In a study on human umbilical vein endothelial cells, Hwang et al. showed that PGRN reduced the expression levels of VCAM-1 and ICAM-1 through the nuclear factor- kappa B pathway, thus it could decrease the activity of inflammatory processes promoting atherosclerosis [46]. The gene discussed is ICAM1; the disease is atherosclerosis.